What clinical evidence do I need? This is a critical question for anyone in the medical device development space.
The problem is, without the right approach it’s impossible to answer this correctly. Too many manufacturers spend a small fortune on clinical studies that, ultimately, fail to support approval and miss the mark for driving commercial traction.
A well-defined clinical strategy is the answer to these problems.
Leveraging her 20+ years in the field, Sue Kemp from Evistrat Consulting joins our CEO Paul Hercock to take us through a deep-dive into clinical strategy development. We cover: what clinical strategy entails, its interaction with regulatory approvals and commercial decisions, how to develop a strategy, and how to avoid critical mistakes.
A proper clinical strategy should be in place from day one. Sue’s guidance works brilliantly alongside our focus on regulatory compliance, and will help you to spearhead your go-to-market journey while avoiding spending precious time and resource on the ‘wrong type’ of clinical evidence.
For more information on clinical strategy, visit Evistrat Consulting.
To develop a go-to-market plan for FREE, send us a message and state “I need a go to market plan!”
